11 results match your criteria: "Centre Clinico-biologique AMP-CECOS[Affiliation]"
Fertil Steril
October 2024
CECOS et Biologie de la reproduction, Hôpital Jean Verdier, Hôpitaux Universitaires Paris Seine-Saint-Denis, AP-HP, Université Sorbonne Paris Nord, Villetaneuse, France; INSERM U1016-Equipe "Génomique, Epigénétique et Physiologie de la Reproduction," Institut Cochin, Université Paris Descartes-Paris, Paris, France.
Objective: To study karyotypes of >8,200 oocyte donor candidates in nulliparous or multiparous women compared with a reference population.
Design: A retrospective observational multicentric study.
Setting: University Hospital Centers.
Gynecol Obstet Fertil Senol
September 2024
Service de biologie de la reproduction-CECOS, CHU de Rennes, 35000 Rennes, France; Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) UMR_S 1085, CHU de Rennes, université de Rennes, 35000 Rennes, France. Electronic address:
Clin Genet
April 2024
Aix Marseille University, Inserm, MMG, Marseille, France.
Biallelic loss-of-function mutation of NUP210L, encoding a testis-specific nucleoporin, has been reported in an infertile man whose spermatozoa show uncondensed heads and histone retention. Mice with a homozygous transgene intronic insertion in Nup210l were infertile but spermatozoa had condensed heads. Expression from this insertion allele is undefined, however, and residual NUP210L production could underlie the milder phenotype.
View Article and Find Full Text PDFPLoS One
April 2023
Aix Marseille Univ, Avignon Univ, CNRS, IRD, IBME, Marseille, France.
Purpose: After childhood leukemia and hematopoietic stem cell transplantation, hormone replacement therapy is often required to induce puberty because of premature ovarian insufficiency. Observance of this kind of treatment in adolescents and young women seems quite poor, and literature about its acceptance remains scarce; in order to learn about their experience and to better understand their attitude towards hormone replacement therapy, we used qualitative methods.
Design And Patients: 13 young women childhood cancer survivors completed an individual interview.
Gynecol Obstet Fertil Senol
April 2023
CHU de Rennes, service de biologie de la reproduction-CECOS, 35000 Rennes, France. Electronic address:
Objective: New possibilities for using gametes within a couple were created by the French law of August 2, 2021 related to bioethics by opening Assisted Reproductive Technics (ART) to all women. It concerns previously self-preserved gametes, thus avoiding the need for gamete donation. The objective of our study is to evaluate the perception of these new uses by ART practitioners.
View Article and Find Full Text PDFClin Genet
May 2023
Laboratoire de Génétique Chromosomique, CHU Grenoble Alpes, Grenoble, France.
Hum Reprod Open
October 2022
DEFE UMR Inserm 1203, Universités de Montpellier et Toulouse, Toulouse, France.
Study Question: In a non-commercial national gamete donation programme, do the motivations and personality characteristics of candidate sperm and oocyte donors differ according to their parenthood status?
Summary Answer: Moderate differences exist between non-parent and parent candidate donors in motivations for gamete donation and representations as well as in personality characteristics.
What Is Known Already: Several studies have analysed the motivations and experiences of oocyte or sperm donors, but mainly in countries where gamete donation is a commercial transaction, and very few studies have reported results of personality traits using personality inventory tests. No study has specifically investigated the motivations and personality characteristics of candidate gamete donors according to parenthood status.
J Assist Reprod Genet
September 2021
Pôle Femmes-Parents-Enfants, Centre Clinico-biologique AMP-CECOS, Plateforme Cancer et Fertilité ONCOPACA-Corse, Assistance-Publique des Hôpitaux de Marseille (AP-HM), La Conception, 147 bd Baille, 13005, Marseille, France.
Hum Genet
January 2021
Institute for Advanced Biosciences, Team Genetics Epigenetics and Therapies of Infertility, Université Grenoble Alpes, INSERM U1209, CNRS UMR 5309, 38000, Grenoble, France.
Eur J Obstet Gynecol Reprod Biol
October 2020
Assistance-Publique des Hôpitaux de Marseille (AP-HM), Pôle Femmes-Parents-Enfants, Centre Clinico-biologique AMP-CECOS, Plateforme Cancer et Fertilité ONCOPACA-Corse, Marseille, France; Aix Marseille Univ, CNRS, IRD, IMBE, Avignon Université, Marseille, France. Electronic address:
Objective: To present a case series of women with borderline ovarian tumours (BOTs) who underwent oocyte vitrification in addition to fertility-sparing surgery.
Study Design: Observational study of all women referred to a French fertility preservation unit between 2015 and 2019 for counselling regarding a fertility preservation (FP) strategy after BOT fertility-sparing surgery. All eligible women underwent one or more cycles of controlled ovarian stimulation (COS) using an antagonist protocol, followed by oocyte retrieval.
Clin Endocrinol (Oxf)
November 2019
Assistance-Publique des Hôpitaux de Marseille (AP-HM), Pôle Femmes-Parents-Enfants, Centre Clinico-biologique AMP-CECOS, Plateforme Cancer et Fertilité ONCOPACA-Corse, Marseille, France.
Objective: Turner syndrome (TS) is responsible for gonadal dysgenesis with high risk of premature ovarian insufficiency. Little is known about fertility preservation (FP) strategies is this population.
Design: Data from women with TS consulting with a fertility specialist in our FP centre from 2014 to 2018 were retrospectively collected.